Bailard’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,284
| Closed | -$1.11M | – | 433 |
|
|
2017
Q3 | $1.11M | Sell |
11,284
-4,698
| -29% | -$464K | 0.09% | 158 |
|
|
2017
Q2 | $1.62M | Sell |
15,982
-2,881
| -15% | -$292K | 0.13% | 145 |
|
|
2017
Q1 | $2.18M | Buy |
18,863
+13,892
| +279% | +$1.6M | 0.18% | 121 |
|
|
2016
Q4 | $597K | Buy |
4,971
+310
| +7% | +$37.2K | 0.06% | 193 |
|
|
2016
Q3 | $524K | Buy |
4,661
+1,613
| +53% | +$181K | 0.05% | 203 |
|
|
2016
Q2 | $378K | Sell |
3,048
-587
| -16% | -$72.8K | 0.05% | 224 |
|
|
2016
Q1 | $409K | Buy |
+3,635
| New | +$409K | 0.06% | 166 |
|
|
2015
Q4 | – | Sell |
-2,859
| Closed | -$285K | – | 225 |
|
|
2015
Q3 | $285K | Buy |
2,859
+970
| +51% | +$96.7K | 0.04% | 194 |
|
|
2015
Q2 | $215K | Buy |
+1,889
| New | +$215K | 0.03% | 228 |
|